Lawrence T, Rotstein C, Beam T R, Gorzynski E A, Amsterdam D
Department of Medical Technology, School of Medicine, State University of New York, Buffalo 14214.
Antimicrob Agents Chemother. 1993 Apr;37(4):896-900. doi: 10.1128/AAC.37.4.896.
The susceptibilities of 316 gram-positive bacteremic isolates to ramoplanin, vancomycin, and teicoplanin and seven other antibiotics were tested. Ramoplanin demonstrated MICs of < or = 0.25 microgram/ml for at least 99% of Staphylococcus aureus isolates and 100% of coagulase-negative staphylococci tested. For both oxacillin-susceptible and oxacillin-resistant S. aureus and coagulase-negative staphylococci, the activity of ramoplanin surpassed those of both vancomycin and teicoplanin. Ramoplanin and teicoplanin had comparable activities against enterococci and Streptococcus pneumoniae and were superior to vancomycin.
对316株革兰氏阳性菌血症分离株进行了瑞莫拉宁、万古霉素、替考拉宁及其他七种抗生素的药敏试验。瑞莫拉宁对至少99%的金黄色葡萄球菌分离株和100%的凝固酶阴性葡萄球菌的最低抑菌浓度（MIC）≤0.25微克/毫升。对于对苯唑西林敏感和耐药的金黄色葡萄球菌及凝固酶阴性葡萄球菌，瑞莫拉宁的活性均超过万古霉素和替考拉宁。瑞莫拉宁和替考拉宁对肠球菌和肺炎链球菌的活性相当，且优于万古霉素。
